Skip to main content
Filing year 2024

CONGENITAL HYPERINSULINISM INTERNATIONAL

Glen Ridge, New Jersey·EIN 20-3068945·NTEE G12 · Diseases, Disorders & Medical Disciplines·3
Total revenue
$1.3M
Total assets
$2.2M
Total expenses
$0
Reported officers
10
Mission

Congenital Hyperinsulinism International (CHI) is a nonprofit 501(c)(3) corporation dedicated to improving the lives of babies, children, and adults affected by congenital hyperinsulinism (HI). HI is a life-threatening genetic disorder that causes severe low blood sugar (hypoglycemia) in infants and children, though in 50% of patients, the genetic cause is unknown. For those with HI, the beta cells of the pancreas secrete too much insulin in an unregulated manner. Excess insulin causes hypoglycemia. Prolonged or severe hypoglycemia can cause seizures, permanent brain damage, or even death if left untreated. A good prognosis is far more likely with a timely diagnosis and proper management.

Executive compensation

Form 990 · Schedule J · 3 reported individuals · Filing year 2024

Base salaryExecutive compensation
Cro
officer (unspecified)
$95k

Plus 7 unpaid individuals.

Browse compensation in Diseases, Disorders & Medical Disciplines

Up 10%
from 2023

From $104k in 2023 to $114k in 2024.

$104k
2023
$114k
2024
Highest reported compensation in each year. Volunteer board members and partial-year payouts are filtered out.

Among peers

Revenue and top compensation, plotted against similar organizations. This organization is highlighted in cyan.

Free, forever
Build lists. Save your benchmarks.
A free Lucido account lets you build lists of nonprofits and save your search filters. No credit card.
Create free account
Already a member? Sign in
Build a benchmark

Compare any role, sector, or revenue band

Build your own benchmark from millions of reported positions.